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Table. Independent Predictors of 3-year Cardiac Mortality
Hazard
ratio
95% Conﬁdence
Interval P Value
Peak CK-MB ratio (per 100
ULN)
1.13 1.04 to 1.22 0.002
Age (per 5 years) 1.20 1.09 to 1.31 0.0001
Diabetes mellitus 2.18 1.42 to 3.33 <0.001
Culprit lesion of proximal LAD 1.62 0.95 to 2.76 0.08
PCI of left main artery 4.19 1.67 to 10.53 0.002
Killip class 2-4 2.45 1.51 to 3.97 <0.001
Baseline creatinine (per 0.1
mg/dL)
1.05 1.03 to 1.07 <0.001
Bivalirudin use (vs. UFH+GPI) 0.47 0.31 to 0.72 <0.001
Acquired thrombocytopenia 1.84 1.19 to 2.87 0.007
Major bleeding 2.53 1.56 to 4.11 <0.001
PCI¼percutaneous coronary intervention; UFH¼unfractionated heparin; GPI¼glycoprotein IIb/
IIIa inhibitor.
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pendent committee. The primary endpoint was target vessel failure (TVF) at 1-year, a
composite of cardiac death, target vessel related MI, and clinically indicated target
vessel revascularization. Secondary endpoints included all the individual components
of the primary endpoint, the incidence of stent thrombosis (ST), and the patient-ori-
ented clinical endpoint (POCE).
Results: Patient and lesion characteristics did not differ between groups with the only
exception being higher proportions of severely calciﬁed lesions (87/548(16%) vs. 108/
500(22%), p¼0.02) and stent postdilatation in EES (402/548 (73%) vs. 400/500
(80%), p¼0.01). At one year, TVF did not differ signiﬁcantly between the two stent
arms (20/421(5%) vs. 15/396 (4%, p¼0.50). In addition, POCE was 8% (32/421) for
ZES and 6% (23/396) for EES (p¼0.31). Deﬁnite-or-probable ST rates were very low
and similar in both groups (2/421 (0.5%) vs. 1/396 (0.3%), p¼1.00).
Conclusions: One-year follow-up of DUTCH PEERS patients, who were treated for
acute MI, demonstrated excellent clinical results with a similar and sustained safety
and efﬁcacy of the Resolute Integrity ZES and the Promus Element EES.
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Background: Primary percutaneous coronary intervention (PPCI) is the treatment of
choice for ST-elevation myocardial infarction (STEMI). The optimum delivery of this
service requires an integrated, multi-disciplinary, consultant-led, protocol-driven
approach. It is widely recognised that resources including availability of medical
personnel are limited during out of working hours, particularly at night. Currently, it is
unclear whether PPCI during working hours is associated with improved outcomes.
Methods:We conducted an observational analysis for 11,461 patients with STEMIwho
underwent PPCI between 2004-2011 at all 8 tertiary cardiac centres in London, UK. The
primary outcome was all-cause mortality at 1 year. We deﬁned working hours as 9am-
5pm (Mon-Fri).We compared outcomes in patients treated out of working hours (OWH)
versus in working hours (IWH). Cox-proportional hazard models built using a stepwise
variable selection process were used to determine independent predictors for mortality.
We used propensity-based matching methods to adjust for measured confounders; and
instrumental variable analyses to adjust for non-measured confounders.
Results: Of the 11,461 patients in the analysis, 7494 patients (65.3%) were treated
with PPCI during OWH. There was no difference in 1-year mortality rates when
comparing OWH vs. IWH (8.6% vs. 7.8%, p¼0.151). Multivariate analysis demon-
strated that PPCI during OWH was not a predictor for 1-year mortality (HR¼1.11,
95%CI: 0.94-1.32, p¼0.201). When stratifying OWH into 2-hourly intervals, multi-
variate analyses demonstrated that there was no particular time interval that was
associated with increased mortality. When analysing 5228 patients in propensity-
matched cohorts, again, PPCI during OWH was not a predictor for 1-year mortality
(HR¼1.10, 95%CI: 0.90-1.34, p¼0.356). Using enrollment year as an instrumental
variable, PPCI during OWH did not affect mortality (absolute difference¼2.1%, 95%
CI:-12.6%,16.8%, p¼0.888).
Conclusions: In this observational analysis of unselected STEMI patients, PPCI
outside routine working hours compared to within routine working hours is safe with
no difference in 1-year mortality.
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Background: This brieﬂy describes the set up and the preliminary results of the “ﬁrst
Nationwide” 24/7 Primary PCI for ST-Elevation Myocardial Infarction Program in the
gulf region.
Methods: In our center over 3500 diagnostic and 1500 Interventional PCI, including
Primary PCI procedures were performed in 2013. With this experience, we proceeded
to setup a nationwide Primary PCI program such that all patients with St-Elevation
Myocardial Infarction (STEMI) were referred seamlessly for immediate Primary PCI
through coordination of all Cardiology, Emergency and Ambulance services in theJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Acwhole country, and under one control and command center. Since its establishment,
we hereby report 422 patients underwent Primary PCI in 6 months. The clinical and
angiographic data were collected and analyzed.
Results: Primary PCI was performed in 422 patients with STEMI (10 months data will
be presented at the conference). Themean age was 50+/-9.5 years. The program allowed
faster and direct transfer of patients to the Primary PCI facility leading very short Door-
to-Balloon Time (DBT) of 52.825 min (>94% of patients were < 90 min). For those
referred from non-Primary PCI facility, 77% had DBT of < 120 min (as stated in the
guidelines)(mean of 8020.7 min). The overall in-hospital mortality for Primary PCI
patients was 2.8%. Radial approach was used in nearly half the patients (43.5%) and
femoral in the other 56.5% with similar DBT for both. More precisely, the time from
arrival to Cath lab to Balloon Dilatation (procedure time) was similar for both ap-
proaches 18.68.3 min for femoral) and (177.2 min for Radial). Overall, less than
TIMI III ﬂow (i.e. TIMI 0, I or II) was found in 85% of patients before Primary PCI, of
these, full TIMI III ﬂow was achieved in 93% of those cases. Achievement of this TIMI
III ﬂow was also similar between Femoral and Radial approaches.
Conclusions: This is the ﬁrst coordinated “Nationwide” Primary PCI program in the
gulf region. The data emphasize how good communication allows Primary PCI for all
STEMI patients, at a very short DBT and with low in-hospital mortality. Radial and
Femoral approaches were used almost equally with similar achievement of TIMI III
ﬂow and procedure time.
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Background: We sought to elucidate: 1) the predictors of enzymatic infarct size
assessed by peak CK-MB in pts with ST-segment elevation myocardial infarction
(STEMI) undergoing primary percutaneous coronary intervention (PCI); and 2) the
impact of peak CK-MB on cardiac mortality at 3 years.
Methods: HORIZONS-AMI was a prospective, open-label, multicenter, dual-arm,
22 factorial randomized trial in pts with STEMI presenting < 12 hours after
symptom onset. The 2 randomization arms consisted of 1) bivalirudin alone vs heparin
plus a glycoprotein IIb/IIIa inhibitor; and 2) TAXUS paclitaxel-eluting stents (PES) vs
bare metal stents (BMS). We evaluated infarct size according to peak CK-MB ratio
(peak-CK-MB/upper limit of normal [ULN]).
Results: Peak CK-MB ratio was available in 3068 of 3345 patients (91.7%). Median
peak CK-MB ratio was 13.9 (IQR 5.8 to 32.4). By linear regression, the independent
predictors of peak CK-MB ratio were US location (p< 0.0001), LAD culprit location
(p< 0.0001), baseline TIMI grade 0/1 ﬂow (p< 0.0001), and post-stent balloon
dilatation (p¼0.04). Beta-blocker use before PCI predicted lower peak CK-MB
(p¼0.03). In a covariate-adjusted Cox regression model, peak CK-MB ratio was an
independent predictor of 3-year cardiac mortality (Table).Conclusions: In this large-scale prospective trial of patients with STEMI undergoing
primary PCI, enzymatic infarct size estimated by peak CK-MB ratio was an inde-
pendent predictor of 3-year cardiac mortality. Further studies are warranted to identify
interventions to reduce infarct size after primary PCI.ute Myocardial Infarction B9
